President Trump Be praised Corona Virus A recent vaccine from a Massachusetts-based biotechnology company is one of two recent “great discoveries” after it announced Monday that the vaccine is 94.5% effective, according to an interim analysis from a late clinical trial.
Moderna’s announcement came after a week Pfizer and BioNTech said their vaccine is 90% more effective.
In a tweet Monday, Trump asked “the great” historians “to remember that these great discoveries, which will end the China epidemic, all happened in my watch!”
The Secretary of Health and Human Services, Alex Azar, praised Moderna’s vaccine as part of President Trump’s “vision” on “Fox and FriendsOn Monday morning.
“This is truly a historic day,” Azar said.
“More good news today from #OperationWarpSpeed: The Moderna / NIH Candidate is now the second vaccine to demonstrate very high efficacy potential in Phase 3 trials,” Azar wrote in TwitterAdding that this is “an amazing result of President Trump’s leadership.”
Trump card Release Operation Warp Speed in the spring as a multi-agency partnership between the federal government and private drugmakers to produce and distribute effective vaccines and treatments. Azar said Warp Speed has committed about $ 2 billion to support Moderna’s vaccine.
The US government previously struck a deal with Moderna for 100 million doses, with an option to purchase an additional 400 million doses.
Ivanka Trump, the president’s daughter and senior adviser, also influenced the news.
“The Moderna / NIH vaccine is the second candidate in a week to demonstrate strong efficacy in Phase 3 trials! Congratulations, Moderna, [President Trump], #OperationWarpSpeed Team and everything that made this historic breakthrough possible – will help put an end to this horrible epidemic! ” Twitter.
Democratic President-elect Joe Biden congratulated the scientists behind Moderna’s vaccine on Monday.
And he wrote: “Today’s news about a second vaccine is an additional reason to feel hopeful.” Twitter. “What was true in the first vaccine remains true for the second one: We are still months away. Until then, Americans need to continue practicing social distancing and wearing masks to control the virus.”
Modern CEO Stefan Bansel He said His company’s coronavirus vaccine on Monday showed a “game-changer” safety record in ongoing studies.
“The people who got our vaccine didn’t get any serious disease, which is of course a game changer,” Bansel told FOX Business Network.Morning with Maria“Monday.
Bancl said that if it gets an emergency use permit from the FDA, Moderna will work with the FDA and the Centers for Disease Control and Prevention to get vaccines for high-risk individuals first.
He told host Maria Bartiromo that 20 million doses would be available by the end of the year.
He added that if other experiments show that the vaccine is safe for students, then young people who are vaccinated next summer can return to a “normal lifestyle” in the fall of the 2021 academic year.
Bancl described the vaccine as “easy to use” because it can last for six months in the regular fridge and seven days in the fridge. The Coronavirus vaccine from Pfizer-BioNTechThe company, which was found to be more than 90% effective in preventing coronavirus in the companies’ phase three clinical trials, should be kept in cooler temperatures, making it more difficult to distribute.
Moderna is Expected to cost It’s somewhere around $ 32 and $ 37 per dose. On the company’s August earnings call, Bancel He said Prices for smaller sizes are likely to range between $ 32 and $ 37 a dose, while larger sizes may be lower.
In its third-quarter earnings statement, Moderna said it received more than $ 1.1 billion in vaccine deposits from governments around the world.
Dr. Anthony Fauci told us today’s show On Monday, the Moderna vaccine data is “impressive” and “extremely impressive,” and that its effectiveness “predicts an impact on this outbreak.”
“This is a really powerful step forward to where we want to be,” Fauci told NBC.
Chris Politician of Fox News and Yael Hallon contributed to this report.